{"id":350100,"date":"2025-08-25T19:02:02","date_gmt":"2025-08-25T19:02:02","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-blueprint-medicines-corporation\/"},"modified":"2025-08-25T19:02:02","modified_gmt":"2025-08-25T19:02:02","slug":"how-to-buy-blueprint-medicines-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","title":{"rendered":"How to buy Blueprint Medicines Corporation (BPMC) shares &#8211; Investment in Blueprint Medicines Corporation (BPMC) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Blueprint Medicines Corporation (BPMC) Shares - Investment in Blueprint Medicines Corporation (BPMC) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Blueprint Medicines Corporation (BPMC) Shares - Investment in Blueprint Medicines Corporation (BPMC) Stock"},"description":"Learn how to buy Blueprint Medicines Corporation (BPMC) shares with current price analysis, 2025-2030 forecasts, and investment strategies for this biotech stock acquisition target.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Blueprint Medicines Corporation (BPMC) shares with current price analysis, 2025-2030 forecasts, and investment strategies for this biotech stock acquisition target."},"intro":"Thinking about investing in one of biotech's most exciting acquisition stories? Blueprint Medicines Corporation (BPMC) represents the perfect blend of scientific innovation and strategic corporate action. With Sanofi's $9.5 billion acquisition underway, this stock offers unique opportunities for both short-term traders and long-term investors. Let's break down everything you need to know about this fascinating biotech play.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in one of biotech's most exciting acquisition stories? Blueprint Medicines Corporation (BPMC) represents the perfect blend of scientific innovation and strategic corporate action. With Sanofi's $9.5 billion acquisition underway, this stock offers unique opportunities for both short-term traders and long-term investors. Let's break down everything you need to know about this fascinating biotech play."},"body_html":"<h2>\ud83d\udcc8 Blueprint Medicines Stock: Current Price and Critical Dates<\/h2> <p>As of August 25, 2025, Blueprint Medicines Corporation (BPMC) trades at <strong>$129.46<\/strong> - right at Sanofi's acquisition offer price. But here's what makes this particularly interesting: the stock already hit its 52-week high of $129.65 in mid-July, showing incredible stability around the acquisition price point.<\/p> <p><strong>Mark your calendar: October 2025 is critical.<\/strong> That's when Blueprint Medicines is expected to release its next earnings report. Historically, these biotech earnings reports create significant price movements.<\/p> <h3>How Earnings Reports Move BPMC Stock<\/h3> <p>Looking at recent history shows a clear pattern:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Price Impact<\/th><th>Duration<\/th><\/tr> <\/thead> <tbody> <tr><td>May 1, 2025<\/td><td>Q1 Earnings<\/td><td>+8.11% surge<\/td><td>3 trading days<\/td><\/tr> <tr><td>February 13, 2025<\/td><td>Q4 2024 Results<\/td><td>+6.3% gain<\/td><td>1 week<\/td><\/tr> <tr><td>October 30, 2024<\/td><td>Q3 Earnings<\/td><td>-4.2% dip<\/td><td>Missed targets<\/td><\/tr> <tr><td>August 1, 2024<\/td><td>Q2 Report<\/td><td>+5.8% climb<\/td><td>Beat estimates<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Positive surprises create immediate 5-8% jumps, while misses cause short-term corrections of 3-5%. The acquisition news has recently stabilized volatility around the $129 offer price.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey (February-August 2025)<\/h2> <p>Blueprint Medicines shares delivered an <strong>impressive 77% gain<\/strong> over the past six months:<\/p> <ul> <li><strong>February 2025<\/strong>: ~$73.04 (post-Q4 earnings dip)<\/li> <li><strong>April 2025<\/strong>: ~$98.60 (approaching 52-week average)<\/li> <li><strong>June 2025<\/strong>: $128.20 (acquisition announcement surge)<\/li> <li><strong>July 2025<\/strong>: $129.36 (peaking at all-time high)<\/li> <li><strong>August 2025<\/strong>: $129.46 (stable at acquisition price)<\/li> <\/ul> <p>Why the massive climb? Three key drivers:<\/p> <ol> <li><strong>Sanofi acquisition news<\/strong> (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-06-02-05-00-00-3091541\">June 2 announcement<\/a>)<\/li> <li><strong>55.5% revenue growth<\/strong> in H1 2025<\/li> <li><strong>AYVAKIT commercial success<\/strong> driving confidence<\/li> <\/ol> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <h3>Near-Term (2025)<\/h3> <p><strong>Current Price<\/strong>: $129.46<br> <strong>Q4 2025 Target<\/strong>: $135-145<br> <strong>Verdict<\/strong>: STRONG BUY - Acquisition provides floor, earnings upside potential<\/p> <h3>2026 Forecast<\/h3> <p><strong>Price Range<\/strong>: $140-160<br> <strong>Rationale<\/strong>: Post-acquisition integration complete, revenue growth continues<\/p> <h3>2028 Outlook<\/h3> <p><strong>Projected Range<\/strong>: $125-135<br> <strong>Analysis<\/strong>: Stable growth under Sanofi umbrella, pipeline development<\/p> <h3>2030 Vision<\/h3> <p><strong>Target Price<\/strong>: $121-128<br> <strong>Long-term<\/strong>: Mature product portfolio, sustainable earnings<\/p> <p><strong>Overall Recommendation<\/strong>: BUY for acquisition arbitrage and near-term gains<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>High volatility<\/strong> (Beta 1.36 - 36% more volatile than market)<\/li> <li><strong>Negative earnings<\/strong> (EPS -2.51, ROE -47.71%)<\/li> <li><strong>Debt concerns<\/strong> ($642.1M debt, though offset by $615.5M cash)<\/li> <li><strong>Regulatory hurdles<\/strong> in pharmaceutical industry<\/li> <li><strong>Integration risks<\/strong> with Sanofi post-acquisition<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>$9.5B acquisition<\/strong> by Sanofi at $129\/share (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-07-18-05-00-00-3117709\">Deal completed July 18<\/a>)<\/li> <li><strong>55.5% revenue growth<\/strong> year-over-year<\/li> <li><strong>AYVAKIT success<\/strong> - heading toward $2B by 2030<\/li> <li><strong>Contingent Value Rights<\/strong> potential additional $6\/share<\/li> <li><strong>Industry trend<\/strong>: Precision medicine growing at 11% annually<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Buy strategically<\/strong> - Use dollar-cost averaging given the acquisition price floor<\/li> <li><strong>Set tight stops<\/strong> - Volatility requires risk management at 5-7% stops<\/li> <li><strong>Watch October earnings<\/strong> - Potential catalyst for movement<\/li> <li><strong>Diversify sensibly<\/strong> - Biotech requires portfolio balance<\/li> <\/ol> <p>Humorous take: \"Trading BPMC is like watching a pharmaceutical clinical trial - 90% waiting, 10% dramatic movement. Bring popcorn for the October earnings show!\"<\/p> <h2>\u2705 How to Buy Blueprint Medicines Corporation (BPMC) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ stocks and competitive fees<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>KYC requirements are standard for stock trading<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>4<\/td><td>Search \"BPMC\"<\/td><td>Use the exact ticker symbol for Blueprint Medicines<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Limit orders recommended around $129-130 range<\/td><\/tr> <tr><td>6<\/td><td>Review and confirm<\/td><td>Check commission rates before finalizing<\/td><\/tr> <tr><td>7<\/td><td>Monitor position<\/td><td>Set price alerts for earnings and news events<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those starting their investment journey, Pocket Option offers several advantages for trading stocks like BPMC:<\/p> <ul> <li><strong>Minimum deposit<\/strong>: Only $5 to start testing strategies<\/li> <li><strong>Rapid verification<\/strong>: Single-document KYC process takes minutes<\/li> <li><strong>Multiple withdrawal options<\/strong>: Over 100 methods including crypto and e-wallets<\/li> <li><strong>User-friendly platform<\/strong>: Perfect for learning stock trading basics<\/li> <li><strong>Educational resources<\/strong>: Access the <a href=\"\/blog\">Pocket Option blog<\/a> for ongoing learning<\/li> <\/ul> <h2>\ud83c\udf0d Blueprint Medicines in 2025: Biotech's Precision Pioneer<\/h2> <p>Blueprint Medicines dominates the precision medicine space with its targeted therapy platform. The company's flagship drug AYVAKIT (avapritinib) has revolutionized treatment for systemic mastocytosis patients. With the Sanofi acquisition completed, Blueprint now benefits from global commercial infrastructure while maintaining its innovative R&D focus.<\/p> <p><strong>2025 interesting fact<\/strong>: During acquisition negotiations, Blueprint's scientists discovered that their BLU-808 compound could be repurposed for allergy treatment - a finding that added significant value to the Sanofi deal and exemplifies the company's innovative culture.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Blueprint Medicines Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 25, 2025, Blueprint Medicines Corporation (BPMC) trades at <strong>$129.46<\/strong> &#8211; right at Sanofi&#8217;s acquisition offer price. But here&#8217;s what makes this particularly interesting: the stock already hit its 52-week high of $129.65 in mid-July, showing incredible stability around the acquisition price point.<\/p>\n<p><strong>Mark your calendar: October 2025 is critical.<\/strong> That&#8217;s when Blueprint Medicines is expected to release its next earnings report. Historically, these biotech earnings reports create significant price movements.<\/p>\n<h3>How Earnings Reports Move BPMC Stock<\/h3>\n<p>Looking at recent history shows a clear pattern:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Price Impact<\/th>\n<th>Duration<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>May 1, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>+8.11% surge<\/td>\n<td>3 trading days<\/td>\n<\/tr>\n<tr>\n<td>February 13, 2025<\/td>\n<td>Q4 2024 Results<\/td>\n<td>+6.3% gain<\/td>\n<td>1 week<\/td>\n<\/tr>\n<tr>\n<td>October 30, 2024<\/td>\n<td>Q3 Earnings<\/td>\n<td>-4.2% dip<\/td>\n<td>Missed targets<\/td>\n<\/tr>\n<tr>\n<td>August 1, 2024<\/td>\n<td>Q2 Report<\/td>\n<td>+5.8% climb<\/td>\n<td>Beat estimates<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Positive surprises create immediate 5-8% jumps, while misses cause short-term corrections of 3-5%. The acquisition news has recently stabilized volatility around the $129 offer price.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey (February-August 2025)<\/h2>\n<p>Blueprint Medicines shares delivered an <strong>impressive 77% gain<\/strong> over the past six months:<\/p>\n<ul>\n<li><strong>February 2025<\/strong>: ~$73.04 (post-Q4 earnings dip)<\/li>\n<li><strong>April 2025<\/strong>: ~$98.60 (approaching 52-week average)<\/li>\n<li><strong>June 2025<\/strong>: $128.20 (acquisition announcement surge)<\/li>\n<li><strong>July 2025<\/strong>: $129.36 (peaking at all-time high)<\/li>\n<li><strong>August 2025<\/strong>: $129.46 (stable at acquisition price)<\/li>\n<\/ul>\n<p>Why the massive climb? Three key drivers:<\/p>\n<ol>\n<li><strong>Sanofi acquisition news<\/strong> (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-06-02-05-00-00-3091541\">June 2 announcement<\/a>)<\/li>\n<li><strong>55.5% revenue growth<\/strong> in H1 2025<\/li>\n<li><strong>AYVAKIT commercial success<\/strong> driving confidence<\/li>\n<\/ol>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<h3>Near-Term (2025)<\/h3>\n<p><strong>Current Price<\/strong>: $129.46<br \/> <strong>Q4 2025 Target<\/strong>: $135-145<br \/> <strong>Verdict<\/strong>: STRONG BUY &#8211; Acquisition provides floor, earnings upside potential<\/p>\n<h3>2026 Forecast<\/h3>\n<p><strong>Price Range<\/strong>: $140-160<br \/> <strong>Rationale<\/strong>: Post-acquisition integration complete, revenue growth continues<\/p>\n<h3>2028 Outlook<\/h3>\n<p><strong>Projected Range<\/strong>: $125-135<br \/> <strong>Analysis<\/strong>: Stable growth under Sanofi umbrella, pipeline development<\/p>\n<h3>2030 Vision<\/h3>\n<p><strong>Target Price<\/strong>: $121-128<br \/> <strong>Long-term<\/strong>: Mature product portfolio, sustainable earnings<\/p>\n<p><strong>Overall Recommendation<\/strong>: BUY for acquisition arbitrage and near-term gains<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>High volatility<\/strong> (Beta 1.36 &#8211; 36% more volatile than market)<\/li>\n<li><strong>Negative earnings<\/strong> (EPS -2.51, ROE -47.71%)<\/li>\n<li><strong>Debt concerns<\/strong> ($642.1M debt, though offset by $615.5M cash)<\/li>\n<li><strong>Regulatory hurdles<\/strong> in pharmaceutical industry<\/li>\n<li><strong>Integration risks<\/strong> with Sanofi post-acquisition<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>$9.5B acquisition<\/strong> by Sanofi at $129\/share (<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-07-18-05-00-00-3117709\">Deal completed July 18<\/a>)<\/li>\n<li><strong>55.5% revenue growth<\/strong> year-over-year<\/li>\n<li><strong>AYVAKIT success<\/strong> &#8211; heading toward $2B by 2030<\/li>\n<li><strong>Contingent Value Rights<\/strong> potential additional $6\/share<\/li>\n<li><strong>Industry trend<\/strong>: Precision medicine growing at 11% annually<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Buy strategically<\/strong> &#8211; Use dollar-cost averaging given the acquisition price floor<\/li>\n<li><strong>Set tight stops<\/strong> &#8211; Volatility requires risk management at 5-7% stops<\/li>\n<li><strong>Watch October earnings<\/strong> &#8211; Potential catalyst for movement<\/li>\n<li><strong>Diversify sensibly<\/strong> &#8211; Biotech requires portfolio balance<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading BPMC is like watching a pharmaceutical clinical trial &#8211; 90% waiting, 10% dramatic movement. Bring popcorn for the October earnings show!&#8221;<\/p>\n<h2>\u2705 How to Buy Blueprint Medicines Corporation (BPMC) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ stocks and competitive fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>KYC requirements are standard for stock trading<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;BPMC&#8221;<\/td>\n<td>Use the exact ticker symbol for Blueprint Medicines<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Limit orders recommended around $129-130 range<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission rates before finalizing<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor position<\/td>\n<td>Set price alerts for earnings and news events<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those starting their investment journey, Pocket Option offers several advantages for trading stocks like BPMC:<\/p>\n<ul>\n<li><strong>Minimum deposit<\/strong>: Only $5 to start testing strategies<\/li>\n<li><strong>Rapid verification<\/strong>: Single-document KYC process takes minutes<\/li>\n<li><strong>Multiple withdrawal options<\/strong>: Over 100 methods including crypto and e-wallets<\/li>\n<li><strong>User-friendly platform<\/strong>: Perfect for learning stock trading basics<\/li>\n<li><strong>Educational resources<\/strong>: Access the <a href=\"\/blog\">Pocket Option blog<\/a> for ongoing learning<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Blueprint Medicines in 2025: Biotech&#8217;s Precision Pioneer<\/h2>\n<p>Blueprint Medicines dominates the precision medicine space with its targeted therapy platform. The company&#8217;s flagship drug AYVAKIT (avapritinib) has revolutionized treatment for systemic mastocytosis patients. With the Sanofi acquisition completed, Blueprint now benefits from global commercial infrastructure while maintaining its innovative R&#038;D focus.<\/p>\n<p><strong>2025 interesting fact<\/strong>: During acquisition negotiations, Blueprint&#8217;s scientists discovered that their BLU-808 compound could be repurposed for allergy treatment &#8211; a finding that added significant value to the Sanofi deal and exemplifies the company&#8217;s innovative culture.<\/p>\n"},"faq":[{"question":"Is BPMC stock still worth buying after the acquisition?","answer":"Yes, the $129 acquisition price provides a floor, and contingent value rights offer additional upside potential based on BLU-808 milestones."},{"question":"What happens to my BPMC shares after the Sanofi acquisition?","answer":"Shares will be converted to cash at $129 per share plus any CVR payments, typically processed automatically through your broker."},{"question":"How volatile is BPMC compared to other biotech stocks?","answer":"With a beta of 1.36, it's more volatile than the market average but typical for clinical-stage biotech companies."},{"question":"What's the biggest risk for BPMC investors?","answer":"Regulatory challenges for drug approvals and integration risks with Sanofi post-acquisition."},{"question":"When is the next major catalyst for BPMC stock?","answer":"October 2025 earnings report and subsequent BLU-808 clinical trial milestones throughout late 2025\/early 2026."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is BPMC stock still worth buying after the acquisition?","answer":"Yes, the $129 acquisition price provides a floor, and contingent value rights offer additional upside potential based on BLU-808 milestones."},{"question":"What happens to my BPMC shares after the Sanofi acquisition?","answer":"Shares will be converted to cash at $129 per share plus any CVR payments, typically processed automatically through your broker."},{"question":"How volatile is BPMC compared to other biotech stocks?","answer":"With a beta of 1.36, it's more volatile than the market average but typical for clinical-stage biotech companies."},{"question":"What's the biggest risk for BPMC investors?","answer":"Regulatory challenges for drug approvals and integration risks with Sanofi post-acquisition."},{"question":"When is the next major catalyst for BPMC stock?","answer":"October 2025 earnings report and subsequent BLU-808 clinical trial milestones throughout late 2025\/early 2026."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Blueprint Medicines Corporation (BPMC) shares - Investment in Blueprint Medicines Corporation (BPMC) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Blueprint Medicines Corporation (BPMC) shares - Investment in Blueprint Medicines Corporation (BPMC) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:02:02+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Blueprint Medicines Corporation (BPMC) shares &#8211; Investment in Blueprint Medicines Corporation (BPMC) stock\",\"datePublished\":\"2025-08-25T19:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\",\"name\":\"How to buy Blueprint Medicines Corporation (BPMC) shares - Investment in Blueprint Medicines Corporation (BPMC) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-25T19:02:02+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Blueprint Medicines Corporation (BPMC) shares &#8211; Investment in Blueprint Medicines Corporation (BPMC) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Blueprint Medicines Corporation (BPMC) shares - Investment in Blueprint Medicines Corporation (BPMC) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Blueprint Medicines Corporation (BPMC) shares - Investment in Blueprint Medicines Corporation (BPMC) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:02:02+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Blueprint Medicines Corporation (BPMC) shares &#8211; Investment in Blueprint Medicines Corporation (BPMC) stock","datePublished":"2025-08-25T19:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/","name":"How to buy Blueprint Medicines Corporation (BPMC) shares - Investment in Blueprint Medicines Corporation (BPMC) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-25T19:02:02+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Blueprint Medicines Corporation (BPMC) shares &#8211; Investment in Blueprint Medicines Corporation (BPMC) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":350169,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"Comment acheter des actions Blueprint Medicines Corporation (BPMC) - Investissement dans Blueprint Medicines Corporation (BPMC) stock","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"it_IT":{"locale":"it_IT","id":350174,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"Come acquistare azioni Blueprint Medicines Corporation (BPMC) - Investimento in azioni Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"pl_PL":{"locale":"pl_PL","id":350171,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"Jak kupi\u0107 akcje Blueprint Medicines Corporation (BPMC) - Inwestycja w akcje Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"es_ES":{"locale":"es_ES","id":350177,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"C\u00f3mo comprar acciones de Blueprint Medicines Corporation (BPMC) - Inversi\u00f3n en acciones de Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"th_TH":{"locale":"th_TH","id":350175,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Blueprint Medicines Corporation (BPMC) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"tr_TR":{"locale":"tr_TR","id":350170,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"Blueprint Medicines Corporation (BPMC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Blueprint Medicines Corporation (BPMC) Hisse Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"vt_VT":{"locale":"vt_VT","id":350173,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Blueprint Medicines Corporation (BPMC) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"},"pt_AA":{"locale":"pt_AA","id":350172,"slug":"how-to-buy-blueprint-medicines-corporation","post_title":"Como comprar a\u00e7\u00f5es da Blueprint Medicines Corporation (BPMC) - Investimento em a\u00e7\u00f5es da Blueprint Medicines Corporation (BPMC)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-blueprint-medicines-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/350100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=350100"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/350100\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=350100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=350100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=350100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}